AxoSim Receives Investment from Benson Capital Partners
Benson Capital Partners Announces First Investment in AxoSim, Inc. AxoSim, Inc, Provider of BrainSim™ & NerveSim™ Neurological Drug Discovery Platforms, and BioFund Portfolio Company, Teams with Benson Capital Partners &…
NOBIC Tenant AxoSim Awarded $870K in Federal Funding
PRESS RELEASE: AxoSim Announces the Award of Over $870K in Federal Grants Overview –Two grants from the DoD Congressionally Directed Medical Research Program and the National Institutes of Health…
News: BioFund Portfolio Company BioAesthetics Raises $2.5 million
News: BioFund Portfolio Company BioAesthetics surpasses $2.5 million target raise BioAesthetics Surpasses Series A Goal, Further Advancing the Nipple-Areolar Complex Graft to Clinical Use BioAesthetics Corporation today announced that it…
LSU HSCNO Spin-Out Awarded $1.9M in STTR Fast Track Funding
NIH STTR GRANT TO FAST TRACK NEW CLASS OF PAIN RELIEVER WITHOUT ADDICTION OR TOXICITY New Orleans, LA – The National Institute of Neurological Disorders and Stroke of the National…
MAJOR NEWS: NOBIC wins $1.5M EDA Award
New Orleans BioInnovation Center Awarded $1.5 Million Grant from U.S. EDA Incubator anticipates creating or retaining 650 jobs and attracting $75 million in private capital NEW ORLEANS (Sep. 17, 2020)…
PRESS RELEASE: ReactWell Receives U.S. Department of Energy Funding
Louisiana Company Receives U.S. Department of Energy Funding LTTO Client Secures Award to Advance an Integrated Carbon Dioxide Capture and Conversion to Ethanol Technology A Louisiana Technology Transfer Office (LTTO)…
NOTICE: Donations for Hurricane Laura Evacuees
Donations for Hurricane Laura Evacuees The New Orleans Health Department and the New Orleans Office of Homeland Security and Emergency Preparedness are working with DCFS to identify evacuee needs that…
AxoSim is Hiring
AxoSim is Hiring Are you looking for a fulfilling career in neurological drug discovery at a rapidly growing startup? AxoSim is looking for a Postdoctoral Researcher and a Research Associate!…
BARDA Update: TMC Innovation Event
BARDA Update: TMC Innovation Event The eradication of any novel biological threat demands the development of groundbreaking technologies and treatments in our biomedical ecosystem. In the face of SARS-CoV-2, the…
Community Upate: Tulane x LSU HSC NOLA COVID-19 Antibody Trial
Community Update: Tulane x LSU HSC NOLA COVID-19 Antibody Trial Tulane and LSU Health Sciences Center New Orleans are running clinical trials for Eli Lilly and Company's COVID-19 antibody therapy…